Related Experiment Video
Updated: Jul 13, 2026
08:44
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
EBV-associated diseases in the AIDS patient
1Department of Biochemistry, St.Jude Children's Research Hospital, Memphis, TN, USA.
Cancer Treatment and Research
|August 4, 2007
Summary
Epstein-Barr virus (EBV)-associated cancers are a significant concern for individuals with HIV, even with modern treatments. Understanding the unique pathogenesis and viral proteins involved is key to developing new therapies for these challenging diseases.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Epstein-Barr virus (EBV) is a common human herpesvirus.
- EBV-associated malignancies pose a significant health challenge for individuals with Human Immunodeficiency Virus (HIV), persisting even with highly active antiretroviral therapy (HAART).
- Each EBV-associated malignancy exhibits a distinct pathogenic pathway.
Purpose of the Study:
- To investigate the viral proteins expressed in EBV-associated malignancies in HIV-infected individuals.
- To elucidate the molecular basis of pathogenesis for these diseases.
- To identify potential targets for novel therapeutic strategies.
Main Methods:
- Analysis of viral protein expression in tumor samples from HIV-infected patients.
- Molecular characterization of pathogenic mechanisms.
- Comparative studies of different EBV-associated malignancies.
Main Results:
- Identification of specific viral proteins implicated in the development of EBV-associated cancers in the context of HIV infection.
- Elucidation of unique molecular pathways contributing to disease pathogenesis.
- Understanding the role of viral proteins in disease progression.
Conclusions:
- Knowledge of viral proteins and molecular pathogenesis is crucial for understanding EBV-associated malignancies in HIV-infected individuals.
- This understanding is expected to facilitate the development of targeted and effective novel therapeutics.
- Future therapeutic interventions hold the promise of improving patient outcomes for these challenging conditions.
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...